Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
about
A Perspective of Immunotherapy for Prostate CancerRole of S100 Proteins in Colorectal CarcinogenesisAdjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate VaccinationPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsMolecular Mechanisms and Metabolomics of Natural Polyphenols Interfering with Breast Cancer MetastasisThe anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growthTasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancerClinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.Clinical development of immunotherapy for prostate cancer.PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment.The Role of Myeloid-Derived Suppressor Cells in Viral Infection.Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.Targeting Inflammation in Cancer Prevention and Therapy.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Nanomedicine Strategies to Target Tumor-Associated Macrophages.Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer.Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors.Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide.Promising immunotherapy for prostate cancer.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment.DNA vaccines for prostate cancer.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer TherapyThe immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis
P2860
Q26741277-B4175684-1151-41DF-AEEF-64D6F82999AEQ26765942-DBED03E6-9BB0-4B2A-88C3-9E16ACF8DFABQ28074536-9E1110A1-5808-4E69-B3DE-A13483A12B73Q28076161-CB7B65BA-F01F-411A-B29F-CF305AF05C90Q28076953-9E0CCB3C-82B5-46C1-8731-297F661CBD1BQ36072831-12F43A68-A67A-48D0-BFEA-8CC32D1B2C2DQ36370409-D96A580C-CA07-4B58-B297-FF9D530238EDQ37113485-05BF849D-3839-42C2-9D97-0A29DBC4F70EQ37348446-52C72634-A952-4889-AF94-1951ADFEB562Q38398117-8BB5AD06-8637-4F91-B21F-5C532A2A9E7DQ38668561-ED76B952-B946-4B0B-91B2-8E2765B76E92Q38699753-7AA64057-ED2F-41BC-83FD-949774656E7CQ38774994-3169680F-024B-4321-B45D-4D63B0415500Q38812152-FE10F0EA-1EAA-4885-94BF-1D6F2E18B2BEQ39027675-7FABC36E-8EC1-4C1A-B66C-5B9ED1622308Q39161005-3C3C2FCF-9048-4FA6-8EE3-1EC3FD2D7805Q39283111-EAF4C8A0-ECE1-4FE3-A8A0-980796C7953EQ41573500-099FA7EA-742D-44CA-963B-CCB745107B8EQ41634246-AC831967-4C65-4714-890F-F8AC4E968FE8Q46125533-5F7AC3D5-F898-4F4E-9B2B-90A5DA0B49B0Q47566793-028445C3-31A1-432F-880C-EADE26BD965CQ47962563-0969E51F-FB1F-44BF-8607-05087C273FFCQ48941494-0B2170BD-3221-4F31-BB75-D51BF6F4B5A2Q51142505-3A90D14F-6CE4-4875-860B-60CCB229B8EDQ57817490-5787A1EB-3E03-4577-84A4-3D1D5A78272CQ58763732-9BB39CBB-F5DE-49D4-880B-708657735CFB
P2860
Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tasquinimod modulates suppress ...... munotherapies in murine models
@ast
Tasquinimod modulates suppress ...... munotherapies in murine models
@en
type
label
Tasquinimod modulates suppress ...... munotherapies in murine models
@ast
Tasquinimod modulates suppress ...... munotherapies in murine models
@en
prefLabel
Tasquinimod modulates suppress ...... munotherapies in murine models
@ast
Tasquinimod modulates suppress ...... munotherapies in murine models
@en
P2093
P2860
P1476
Tasquinimod modulates suppress ...... munotherapies in murine models
@en
P2093
Anders Olsson
Anette Sundstedt
Ashley Orillion
Eric Ciamporcero
Helena Eriksson
Kiersten Marie Miles
Leigh Ellis
Michael Ciesielski
Mona Celander
P2860
P304
P356
10.1158/2326-6066.CIR-14-0036
P577
2014-11-04T00:00:00Z